HLS Therapeutics, Inc. operates as a pharmaceutical company. It focuses on clinically differentiated pharmaceutical products in the specialty central nervous system CNS) and cardiovascular (CV) markets. The company was founded by Gregory Gubitz, Gilbert Godin and William McDowall Wells on March 12, 2018 and is headquartered in Etobicoke, Canada.
TSX